![Emirates Dermatology Society And Novartis Launch 'Skin To Live In' A Groundbreaking Campaign For People Living With Psoriasis - Health Magazine Emirates Dermatology Society And Novartis Launch 'Skin To Live In' A Groundbreaking Campaign For People Living With Psoriasis - Health Magazine](https://healthmagazine.ae/wp-content/uploads/2017/12/Psoriasis-Infographics-EN-1.jpg)
Emirates Dermatology Society And Novartis Launch 'Skin To Live In' A Groundbreaking Campaign For People Living With Psoriasis - Health Magazine
![Ben Goldacre on Twitter: "@NDevito1 @sebbacon Compliance with this law is very poor. But it is also *staying* poor: it is not improving over time. You can see for yourself in the Ben Goldacre on Twitter: "@NDevito1 @sebbacon Compliance with this law is very poor. But it is also *staying* poor: it is not improving over time. You can see for yourself in the](https://pbs.twimg.com/media/EOhhDJ_XkAAQxZB.jpg)
Ben Goldacre on Twitter: "@NDevito1 @sebbacon Compliance with this law is very poor. But it is also *staying* poor: it is not improving over time. You can see for yourself in the
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
![PANCREATIC CANCER ACTION NETWORK ADAPTIVE CLINICAL TRIAL ADDS NEW INVESTIGATIONAL TREATMENT AND ADDITIONAL SITES PANCREATIC CANCER ACTION NETWORK ADAPTIVE CLINICAL TRIAL ADDS NEW INVESTIGATIONAL TREATMENT AND ADDITIONAL SITES](https://mma.prnewswire.com/media/1772930/Precision_Promise_Map.jpg?p=facebook)
PANCREATIC CANCER ACTION NETWORK ADAPTIVE CLINICAL TRIAL ADDS NEW INVESTIGATIONAL TREATMENT AND ADDITIONAL SITES
![Novartis taps Ada Health's AI diagnosis platform for tracking rare, immunological conditions | Fierce Biotech Novartis taps Ada Health's AI diagnosis platform for tracking rare, immunological conditions | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1620925703/Ada-Health-Test.jpg?VersionId=EFmhfNYrjkc3gswzR2D4Bo4.oDg.zwO.)
Novartis taps Ada Health's AI diagnosis platform for tracking rare, immunological conditions | Fierce Biotech
![Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2022/10/1613606_3867152_0035.jpg)
Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients - Mayo Clinic News Network
![PDF) Burden and Incidence of Multimorbidity in Systemic Lupus Erythematosus in a Community Population-Based Cohort: The Lupus Midwest Network PDF) Burden and Incidence of Multimorbidity in Systemic Lupus Erythematosus in a Community Population-Based Cohort: The Lupus Midwest Network](https://i1.rgstatic.net/publication/371000743_Burden_and_Incidence_of_Multimorbidity_in_Systemic_Lupus_Erythematosus_in_a_Community_Population-Based_Cohort_The_Lupus_Midwest_Network/links/646e1b706a0082273fa86bc9/largepreview.png)
PDF) Burden and Incidence of Multimorbidity in Systemic Lupus Erythematosus in a Community Population-Based Cohort: The Lupus Midwest Network
![Novartis teams up with smartpatient on new tool for patients with wet macular degeneration | MobiHealthNews Novartis teams up with smartpatient on new tool for patients with wet macular degeneration | MobiHealthNews](https://www.mobihealthnews.com/sites/default/files/Novartis%20app.png)
Novartis teams up with smartpatient on new tool for patients with wet macular degeneration | MobiHealthNews
![Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy | Science Advances Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy | Science Advances](https://www.science.org/cms/10.1126/sciadv.abl6339/asset/85c8b33a-1862-4d0c-9784-7abf7e9e0cbd/assets/images/large/sciadv.abl6339-f1.jpg)
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy | Science Advances
![H1, Which Operates A Healthcare Professional Network To Streamline Clinical Trials, Raises $100M To Accelerate Growth - CB Insights Research H1, Which Operates A Healthcare Professional Network To Streamline Clinical Trials, Raises $100M To Accelerate Growth - CB Insights Research](https://research-assets.cbinsights.com/2021/11/19045145/H1.png)